Search

Comparing Microsoft, Bitcoin, and small-cap stocks might seem like comparing apples to bananas to oranges, but if you dig deeper into that comparison you’ll see why I like small-cap stocks.

We comment on earnings from several recommended companies. Also, we raise our price targets for three stocks that have moved above our existing price targets. And, rooting for the turnaround Cincinnati Bengals.

It’s changes in perceptions make stocks move. And these perceptions are reflected in the chart.

It’s easy to sell people on the promise of huge returns, but investors are in danger of underestimating risk.

As we close out the fourth week of 2019 small caps are looking good.

Holding a great growth stock forever can be smart. Excellent stock-picking combined with a bull market can be rewarding.

Dividends are the most reliable indication of a company’s growth and stability. Dividends are the payments of a company’s hard-earned profits. A company’s ability to continually pay dividends provides concrete evidence that the company is performing well.

No one knows for sure where the stock market is headed. But these two global megatrends are clear. And these two stocks should benefit.

In today’s Dividend Edition, I have three investment ideas that will hold particular appeal for anyone who’s ever had to make mortgage payments. That’s because these ideas are all ways for you to make money off others’ mortgages! We’ll start with the lowest-risk, lowest-yielding idea and work our way up. My...

Drug manufacturing is a $160 billion market, with $30 billion in profits. By 2020, sales are expected to top $170 billion. That bodes well for drug stocks.

Patience remains a virtue in this market, as the major indexes and individual stocks have been unable to get going, though for the most part, sellers have failed to take control, too. We’ll see if today changes that; today’s post-Fed selling was ugly, though it hasn’t cracked our Tides buy signal or most stocks that were setting up. Either way, we’re remaining defensive, with nearly three quarters of the portfolio in cash.

Tonight’s issue is very stock heavy, with a big watch list and write-ups on on a variety of names (including some recent IPOs) that are acting well and have great stories. We continue to think a few good days could make all the difference, but until we see it happen, less remains more as we keep our eyes open for signs the buyers are showing up and the sellers have left the building.

This week’s action has been a disappointment, with growth stocks suffering selling while defensive names have picked up steam. Still, nothing much has changed--the top-down evidence is mixed, and growth stocks, while taking on water, haven’t suffered anything abnormal to this point. Thus, given that we’re about half in cash, we’re mostly standing pat in the Model Portfolio tonight.

We recently conducted a short survey of our Dick Davis Investment Digest subscribers. Several common concerns were market volatility and economic uncertainty (which I wrote about two weeks ago here). Today, I want to address a third common refrain. As a subscriber from Texas put it: “Maximize dividend income...

The major indexes all closed last week near their highs, which is one big factor keeping the top-down evidence very bullish; nothing has changed with our big picture positive thoughts. That said, right now, we don’t think the situation is as strong as the indexes suggest—just looking at a variety of names, it’s clear many are consolidating even as the S&P and Nasdaq tested new high ground late last week. Again, we’re not saying that’s a big bugaboo, but right now, we continue to think being more discerning when looking for entry points makes sense, as does pruning some laggards if you have them. We’ll keep our Market Monitor at a level 7.

This week’s list has something for everyone, with a decent amount of cyclical exposure but also some true blue growth names as well. Our Top Pick is helping to lead a new group move in metal stocks in general (and copper in particular).

The November market rally continues, as signs of renewed health among stocks are popping up in more and more places – including in the Stock of the Week portfolio. So today, we’re only adding – and upgrading. The new addition is a longtime recommendation by Cabot Dividend Investor Chief Analyst, Tom Hutchinson, and one that’s having a surprisingly good year. Lately, it’s gone into overdrive and yet still trades well below its highs. We try and capture the stock’s newfound momentum as we head into the holiday season.

Enjoy – and Happy Thanksgiving!

This market is officially flirting with ugly. The S&P is now down about 7% from the 52-week high and not far from correction territory, down 10% from the high.

The selling intensified over the last week after the Fed struck an unexpectedly hawkish tone at last week’s meeting. The gist of the Fed’s message is that rates may well go higher and will stay higher for longer. The statement pours cold water on the notion that rates will be cut in the near future and reinforces the realization that higher rates are here to stay.

The market is distinctly more optimistic this month as “soft landing’ hopes revive.

After a rough couple of months, the S&P is trending higher in October. The economy is still solid. In fact, retail sales numbers for September blew away expectations, once again showing that a recession is nowhere in sight.